DSR Biomaterials
Surface modification and biomaterials consultancy for healthcare, diagnostics and materials science companies
Highlights
- New on EvolcAdded 2026-11-13
About DSR Biomaterials
DSR Biomaterials provides strategic and technical consultancy on surface modification, coatings and biomaterials development. Services include product development, testing and validation, scale-up, manufacturing and contract research.
It supports organisations in healthcare, diagnostics and materials science through research, development and commercialisation, including coating strategies, biocompatibility, drug delivery and quality compliance. The company is registered in Bromley, United Kingdom, and was founded in 2020.
Product: Consultancy and strategic support for surface modification, coating technologies and biomaterials development.
Jobs at DSR Biomaterials
More biotech & pharma companies
Duke Street Bio
Develops cancer therapies targeting DNA damage repair deficiencies for patients with cancerE.V.A Biosystems
Biological additives for plastic manufacturers to make conventional plastics selectively degradable in target environmentsNew on EvolcEarlham Enterprises
Contract research and genomics services for academic, public-sector, nonprofit and private organisationsEco Animal Health
Veterinary medicines and vaccines for pig, poultry and cattle producers, sold directly and through distributors in over 70 countriesNew on EvolcEcotype Genetics
DNA testing and species identification services for ecologists, conservation groups and environmental researchers in the UKNew on EvolcElasmogen
Biopharma developing ELN28, a dual-acting TNFα and JAK inhibitor conjugate for hidradenitis suppurativa patients
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.